06 January 2004
Aneurysm: prevention and nonsurgical repairJohn T.A. Ely
Med Sci Monit 2004; 10(1): HY1-4 :: ID: 11560
The approximately 4000 ‘normal’ mammals that synthesize ascorbic acid produce on average circa 50 mg/kg per day routinely. Although humans have the same needs as normal mammals, they do not produce ascorbic acid at all and, on average, ingest only circa 1 mg/kg per day. The normal mammals’ much larger production enables them to continually renew structural proteins, including both collagen, a flexible but inelastic tissue, and elastin, the elastic connective tissue. As a result, many normal mammals maintain a ‘youthful’ appearance with little gross anatomical change from age of maturity (i.e, first estrus) to more than 20 times age of maturity. In stark contrast, the extremely small ascorbic acid intake of humans does not enable them to maintain a youthful flexibility and elasticity beyond possibly 6 times age of maturity (most have died before 8 times). This loss of youthful qualities in structural proteins results in susceptibility for many forms of deterioration in both appearance and properties of vascular and other structural tissues. One such deterioration is aortic aneurysm, a common cause of morbidity and mortality. We hypothesize herein that improved dietary intake of essential nutrients needed to enhance the renewal of all structural proteins can: (1) prevent this deterioration completely; and (2) cure even large aortic aneurysms without surgery.
Keywords: Aortic Aneurysm - diet therapy, Aortic Aneurysm - metabolism, Aortic Aneurysm - prevention & control, Ascorbic Acid - administration & dosage, Collagen - metabolism, Elastic Tissue - metabolism, Elastin - metabolism, Longevity, Models, Cardiovascular, Aortic Aneurysm - prevention & control, Ascorbic Acid - administration & dosage, Collagen - metabolism, Elastic Tissue - metabolism, Elastin - metabolism, Longevity, Models, Cardiovascular
01 May 2023 : EditorialEditorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor Therapy
Med Sci Monit 2023; 29:e940911
31 May 2023 : Review articlePrevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A Review
Med Sci Monit In Press; DOI: 10.12659/MSM.939919
30 May 2023 : Clinical ResearchA Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...
Med Sci Monit In Press; DOI: 10.12659/MSM.940409
30 May 2023 : Review articleA Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...
Med Sci Monit In Press; DOI: 10.12659/MSM.940550
30 May 2023 : Database AnalysisThe COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in Poland
Med Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : EditorialEditorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...
Med Sci Monit 2022; 28:e935952